Researchers found that women who experience early menopause do not live as long and experience more years with type 2 diabetes mellitus.
FDA Approves Femlyv, First Orally Disintegrating Tablet for Birth Control
Femlyv (norethindrone acetate and ethinyl estradiol) may expand access to contraception as an option for individuals with swallowing difficulties.
Postpartum Transition Support Increases Primary Care Engagement, Reduces Risk of Readmission
Providing postpartum scheduling support increased the odds of a primary care visit within 4 months of childbirth among women with chronic disease and improved monitoring.
Rapid Rise in Rates of Diabetes During Pregnancy in Canada Not Expected to Slow
The most concerning escalation in type 1, type 2, and gestational diabetes has been among the youngest women and girls, aged 15 to 19 years, report study authors.
Massachusetts Standing Orders Increase Emergency Contraceptive Access
Following the statewide order in August 2022, emergency contraceptive fills at Massachusetts pharmacies increased by 32% compared with rates in other states.
Prenatal RSV Vaccine Not Associated with Preterm Birth, According to First Real-World Data
Data from a study performed during the first season the shot was available expand on clinical trial evidence and support the safety of RSVpreF, authors wrote.
Sex Disparities in Long-Term Lipid Management: Daily Dose
Your daily dose of the clinical news you may have missed.